COVID-19 International Modelling Consortium, a participatory approach to pandemic modelling involving researchers @uniofoxford @cornell & 42 countries globally

Joined December 2020
Our NEW training programme, Strategic Modelling for Public Health Policy, launches today. Aimed at entry level modellers working in a range of sectors. Courses start 24 April. For more information and to sign up click here: como-international.github.io…
3
2
265
Our NEW training programme, Strategic Modelling for Public Health Policy, launches today. Aimed at entry level modellers working in a range of sectors. Courses start 24 April. For more information and to sign up click here: como-international.github.io…
3
2
265
VACANCY: Do you have a PhD/DPhil in a topic related to global health modelling with experience of teaching and research? We are recruiting for a Teaching Co-ordinator on the MSc in Modelling for Global Health. Apply by 28 June👇my.corehr.com/pls/uoxrecruit… @NDMOxford @OxfordMedSci
1
3
3
1,013
New blog in Nature Microbiology Community: Behind the paper: “Potential health and economic impacts of dexamethasone treatment for patients with COVID-19” naturemicrobiologycommunity.…
1
Vaccines dominate the headlines but the significance of this cost-effective option for the management of severe COVID-10 patients and its potential to save lives is key. New research by @rimashretta @rjaaguas @lisawhite1000 @PeterHorby @MartinLandray
Dexamethasone could have saved 7,647- 22,406 lives translating to GBP 940 per life year gained in the UK. nature.com/articles/s41467-0…
1
1
3/3 Essential now to perform clinical research in low- and middle-income countries with limited access to oxygen and/or ventilators.
2/3 NEW study by @ComoConsortium researchers in Nature Comms nature.com/articles/s41467-0… estimates the potential number of lives saved and life-years gained if this treatment were to be rolled out in the UK and globally, as well as the cost-effectiveness of this intervention.
1
1/3 In June 2020, the #recoverytrial a large, multicenter, randomized, open-label trial performed in the UK reported that dexamethasone administered for 10 days reduced mortality in hospitalised COVID-19 patients needing oxygen and ventilation by 18% and 36%, respectively.
1
CoMo Consortium retweeted
A widely used drug for many years that has played a major role in decreasing COVID-19 mortality recently and is incredibly cost effective. Unfortunately was not recommended for use earlier in th the pandemic. nature.com/articles/s41467-0…
2
2
National consortium to study threats of new SARS-CoV-2 variants medsci.ox.ac.uk/news/nationa…
7
10
Brand new course! MSc Modelling for Global Health. A full-time 1 year programme to train a new modellers with cutting edge multi-disciplinary skills supporting developing global health systems. @oxunistudents @uniofoxford @OxfordMedSci ox.ac.uk/admissions/graduate…